Substance P Antagonist Aprepitant Shows no Additive Effect Compared with Standardized Topical Treatment Alone in Patients with Atopic Dermatitis

• Hoofdauteurs: Louise Lönndahl (Auteur), Mikael Holst (Auteur), Maria Bradley (Auteur), Hassan Killasli (Auteur), Johan Heilborn (Auteur), Martin A. Hall (Auteur), Elvar Theodorsson (Auteur), Jadwiga Holmberg (Auteur), Klas Nordlind (Auteur)
• Formaat: Boek
• Gepubliceerd in: Medical Journals Sweden, 2017-12-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Atopic dermatitis (AD) is a chronic, itchy, inflammatory skin disorder that may worsen due to stress and anxiety. Tachykinins have been suggested to be involved in the inflammation in AD, as well as pruritus. Aprepitant is a NK-1 receptor antagonist. This open randomized trial evaluated the effect o...